The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
The Molecular Basis of Nonoxynol‐9–Induced Vaginal Inflammation and Its Possible Relevance to Human Immunodeficiency Virus Type 1 Transmission
Abstract
Topical microbicides are being sought to prevent sexually transmitted diseases by inactivating pathogens while preserving or enhancing the natural mucosal barrier. Serious public health concerns were raised by a recent phase 3 clinical trial that showed that nonoxynol-9 (N-9), a leading microbicide candidate widely used as an over-the-counter spermicide, may actually increase human immunodeficiency virus type 1 (HIV-1) transmission. The present study links N-9-induced vaginal inflammation to increased risk of HIV-1 infection. Analysis of molecular and cellular components in cervicovaginal secretions, as well as results from in vitro activation of cervicovaginal epithelial cells and U1/HIV promonocytic cells, showed that multiple N-9 use can promote HIV-1 transmission through interleukin-1-mediated NF-kappaB activation, which leads to chemokine-induced recruitment of HIV-1 host cells and increased HIV-1 replication in infected cells. Furthermore, this study identifies in vitro and in vivo model systems for monitoring undesirable proinflammatory effects of microbicides and other vaginal products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., & Wallach, D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.323 · Cited by 814
O'Neill, L. A. J., & Greene, C. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.6.650 · Cited by 561
Zhang, H., Dornadula, G., Beumont, M., Livornese, L., Van Uitert, B., Henning, K., & Pomerantz, R. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392502 · Cited by 427
The candidate oncoprotein Bcl-3 is an antagonist of pSO/NF-κB-mediated inhibition
Franzoso, G., Bours, V., Park, S., Tomfta-Yamaguchi, M., Kelly, K., & Siebenlist, U. (1992) · Nature · doi:10.1038/359339a0 · Cited by 319
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
Gabay, C., Smith, M. F., Eidlen, D., & Arend, W. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119488 · Cited by 319
Fichorova, R. N., Rheinwald, J. G., & Anderson, D. J. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.4.847 · Cited by 313
Self-citationMcNeely, T. B., Shugars, D. C., Rosendahl, M., Tucker, C., Eisenberg, S. P., & Wahl, S. M. (1997) · Blood · doi:10.1182/blood.v90.3.1141 · Cited by 253
Safety Study of Nonoxynol-9 as a Vaginal Microbicide: Evidence of Adverse Effects
Stafford, M. K., Ward, H., Flanagan, A., Rosenstein, I. J., Taylor-Robinson, D., Smith, J. R., Weber, J., & Kitchen, V. S. (1998) · Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology · doi:10.1097/00042560-199804010-00006 · Cited by 237
The Effects of Frequent Nonoxynol-9 Use on the Vaginal and Cervical Mucosa
NIRUTHISARD, S., RODDY, R. E., & CHUTIVONGSE, S. (1991) · Sexually Transmitted Diseases · doi:10.1097/00007435-199107000-00010 · Cited by 205
Fichorova, R. N., & Anderson, D. J. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.2.508 · Cited by 190
Self-citationPoli, G., Kinter, A. L., & Fauci, A. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.108 · Cited by 183
Achieving transcriptional specificity with nf-κb
Perkins, N. D. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00088-5 · Cited by 183
Molecular Basis of Latency in Pathogenic Human Viruses
García-Blanco, M. A., & Cullen, B. R. (1991) · Science · doi:10.1126/science.1658933 · Cited by 163
Endtz, A. W. (1974) · PubMed · Cited by 109
Damme, L. V., Chandeying, V., Gita Ramjee, H., Rees, H., Sirivongrangson, P., Laga, M., & Perriëns, J. (2000) · AIDS · doi:10.1097/00002030-200001070-00010 · Cited by 98
Expression and Activation of NF-κB in the Antrum of the Human Stomach
van den Brink, G. R., ten Kate, F. J. W., Ponsioen, C. Y., Rive, M. M., Tytgat, G. N. J., van Deventer, S. J. H., & Peppelenbosch, M. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3353 · Cited by 88
Körting, H. C., Schindler, S., Hartinger, A., Kerscher, M., Angerpointner, T. A., & Maibach, H. I. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00746-2 · Cited by 77
Widely Used Spermicide May Increase, Not Decrease, Risk of HIV Transmission
Stephenson, J. (2000) · JAMA · doi:10.1001/jama.284.8.949 · Cited by 70
Granowitz, E. V., Saget, B. M., Wang, M. Z., Dinarello, C. A., Skolnik, P. R., & Fauci, A. S. (1995) · Molecular Medicine · doi:10.1007/bf03401607 · Cited by 58
Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection
Damme, L. V., Niruthisard, S., Atisook, R., Boer, K., Dally, L., Laga, M., Lange, J. M. A., Karam, M., & Perriëns, J. H. (1998) · AIDS · doi:10.1097/00002030-199804000-00013 · Cited by 53
Mallardo, M., Dragonetti, E., Baldassarre, F., Ambrosino, C., Scala, G., & Quinto, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20820 · Cited by 50
Al‐Harthi, L., Spear, G. T., Hashemi, F. B., LANDAY, A. L., Sha, B. E., & Roebuck, K. A. (1998) · The Journal of Infectious Diseases · doi:10.1086/314444 · Cited by 44
Loré, K., Sönnerborg, A. B., Olsson, J., Patterson, B. K., Fehniger, T. E., Perbeck, L. G., & Andersson, J. (1999) · AIDS · doi:10.1097/00002030-199910220-00003 · Cited by 32
Cited by
In Vitro and In Vivo: The Story of Nonoxynol 9
Hillier, S. L., Moench, T., Shattock, R., Black, R., Reichelderfer, P., & Veronese, F. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000159671.25950.74 · Cited by 572
Genital Inflammation and the Risk of HIV Acquisition in Women
Masson, L., Passmore, J.-A. S., Liebenberg, L. J., Werner, L., Baxter, C., Arnold, K. B., Williamson, C., Little, F., Mansoor, L. E., Naranbhai, V., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ298 · Cited by 422
Pudney, J., Quayle, A. J., & Anderson, D. J. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.043133 · Cited by 373
Self-citationYasin, B., Wang, W., Pang, M., Cheshenko, N., Hong, T., Waring, A. J., Herold, B. C., Wagar, E. A., & Lehrer, R. I. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5147-5156.2004 · Cited by 254
Inácio, Â. S., Mesquita, K. A., Baptista, M., Ramalho-Santos, J., Vaz, W. L. C., & Vieira, O. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019850 · Cited by 141
“Earlier studies identified vaginal columnar epithelial cells as the most important site of damage caused by the surfactants Nonoxynol-9 [10,20] and C31G [19] in humans.”
Background
Metadata
- Authors
- Fichorova, R. N., Tucker, L. D., & Anderson, D. J.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-08-15
- Volume
- 184
- Issue
- 4
- Pages
- 418-428
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2080499742
- Cited by
- 302
- References
- 25
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.